#2420 - Chris Masterjohn

What It Covers

Chris Masterjohn explains mitochondrial function as the foundation of health and aging, covering creatine's cognitive benefits, red light therapy mechanisms, CoQ10 dosing strategies, seed oil controversies, and why gymnasts live eight years longer than average populations.

Key Questions Answered

• •Creatine for Brain Health: Twenty grams daily of creatine during sleep deprivation improves cognitive performance and reduces fatigue complaints. Clinical trials show this dose doubles healing rates in traumatic brain injury over six months. Most people eating less than one to two pounds of meat daily should supplement creatine.
• •Mitochondrial Decline and Aging: Mitochondrial function decreases one percent per year from age eighteen to seventy, resulting in fifty percent energy loss by age seventy. Age explains only twenty-five percent of mitochondrial function variance, meaning seventy-five percent remains under individual control through nutrition, exercise, and lifestyle interventions.
• •CoQ10 Dosing Window: Clinical trials show optimal benefits at one hundred to two hundred milligrams daily for average glucose, insulin, and blood pressure improvements. Four hundred milligrams daily worsens these markers for most people. Heart contains the highest food concentrations, approximately ten times more than other sources.
• •Exercise Diversity for Longevity: Gymnasts and pole vaulters live eight years longer than general populations, six years longer than cyclists. The combination of full-body coordination, frequent inversion, stretching, and diverse movement patterns appears more protective than cardiorespiratory fitness alone for cancer and neurological disease prevention.
• •Seed Oil Long-Term Effects: The LA Veterans Administration Hospital study tracked participants for eight years, showing cancer rates diverged after two years, with seed oil groups experiencing significantly higher mortality. Tissue fatty acid composition takes four years to fully reflect dietary oil changes, explaining why short-term trials miss harmful effects.